The estimated Net Worth of Anthony J Sinskey is at least 19 千$ dollars as of 15 August 2022. Anthony Sinskey owns over 6,000 units of Yield10 Bioscience Inc stock worth over 19,040$ and over the last 13 years he sold YTEN stock worth over 0$. In addition, he makes 0$ as Independent Director at Yield10 Bioscience Inc.
Sign up
Anthony Sinskey YTEN stock SEC Form 4 insiders trading
Anthony has made over 12 trades of the Yield10 Bioscience Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of YTEN stock worth 16,800$ on 15 August 2022.
The largest trade he's ever made was exercising 25,000 units of Yield10 Bioscience Inc stock on 25 August 2014 worth over 31,250$. On average, Anthony trades about 2,467 units every 79 days since 2012. As of 15 August 2022 he still owns at least 17,309 units of Yield10 Bioscience Inc stock.
You can see the complete history of Anthony Sinskey stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Anthony Sinskey biography
Dr. Anthony J. Sinskey, Sc.D. is an Independent Director of the Company. He is a co-founder of Metabolix, has served as a director since June 1992. From 1968 to present, Dr. Sinskey has been on the faculty of MIT. Currently at MIT, he serves as professor of microbiology in the Department of Biology and professor of health sciences and technology in the Harvard-MIT Health Sciences and Technology Program Engineering Systems Division, as well as faculty director of the Center for Biomedical Innovation. Dr. Sinskey serves on the board of directors of Tepha, Inc. (see "Certain Relationships and Related Person Transactions"). Dr. Sinskey received a B.S. from the University of Illinois and a Sc.D. from MIT. The Board believes that, as a faculty member of an academic institution with significant research activity in areas related to the Company's own research, Dr. Sinskey contributes to the Board his scientific knowledge and his awareness of new developments in these fields. Dr. Sinskey's involvement with other start-up and developing enterprises also makes him a valuable Board member.
How old is Anthony Sinskey?
Anthony Sinskey is 77, he's been the Independent Director of Yield10 Bioscience Inc since 1992. There are no older and 7 younger executives at Yield10 Bioscience Inc.
What's Anthony Sinskey's mailing address?
Anthony's mailing address filed with the SEC is C/O YIELD10 BIOSCIENCE, INC., 19 PRESIDENTIAL WAY, SUITE 201, WOBURN, MA, 01801.
Insiders trading at Yield10 Bioscience Inc
Over the last 8 years, insiders at Yield10 Bioscience Inc have traded over 1,212,006$ worth of Yield10 Bioscience Inc stock and bought 4,271,174 units worth 10,113,836$ . The most active insiders traders include Jack W Schuler、Peter N Kellogg、Joseph H Shaulson. On average, Yield10 Bioscience Inc executives and independent directors trade stock every 107 days with the average trade being worth of 238,638$. The most recent stock trade was executed by Jack W Schuler on 20 December 2023, trading 36,000 units of YTEN stock currently worth 7,200$.
What does Yield10 Bioscience Inc do?
yield10 bioscience, inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the united states and canada. the company, through its trait factory, is involved in developing high value seed traits for the agriculture and food industries. it also has an oilseed development center in saskatchewan, canada. yield10 bioscience, inc. has research agreements with bayer ag to develop traits in soybean; forage genetics international, llc to develop traits in forage sorghum; j. r. simplot company to develop novel traits in potato; and gdm seeds inc. to evaluate yield traits in soybeans. the company was formerly known as metabolix, inc. and changed its name to yield10 bioscience, inc. in january 2017. yield10 bioscience, inc. was founded in 1992 and is headquartered in woburn, massachusetts.
What does Yield10 Bioscience Inc's logo look like?
Complete history of Anthony Sinskey stock trades at Merrimack Pharmaceuticals Inc、Yield10 Bioscience Inc
Yield10 Bioscience Inc executives and stock owners
Yield10 Bioscience Inc executives and other stock owners filed with the SEC include:
-
Joseph Shaulson,
Director -
Oliver Peoples,
President, Chief Executive Officer, Director -
Lynne Brum,
Vice President - Planning and Communications -
Charles Haaser,
Chief Accounting Officer, Vice President - Finance -
Anthony Sinskey,
Independent Director -
Richard Hamilton,
Director -
Sherri Brown,
Director -
Sarah Cecil,
General Counsel, Secretary -
Kristi Snell,
Chief Science Officer, Vice President - Research -
Robert Van Nostrand,
Chairman of the Board, Independent Director -
Peter N Kellogg,
Director -
Jack W Schuler,
-
Willie Loh,
Director